Published in Cochrane Database Syst Rev on January 28, 2015
Animal models of osteoarthritis: classification, update, and measurement of outcomes. J Orthop Surg Res (2016) 0.90
Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT). Ann Rheum Dis (2017) 0.82
Chondroitin sulphate: a focus on osteoarthritis. Glycoconj J (2016) 0.81
Glucosamine and chondroitin for the treatment of osteoarthritis. World J Orthop (2017) 0.75
Mefenamic acid decreases inflammation but not joint lesions in experimental osteoarthritis. Int J Exp Pathol (2016) 0.75
Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study. Arthritis Res Ther (2016) 0.75
Effect of glucosamine on intraocular pressure: a randomized clinical trial. Eye (Lond) (2016) 0.75
Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses' Health Study and Health Professionals follow-up study. Int J Cancer (2016) 0.75
Chondroitin sulfate disaccharides modified the structure and function of the murine gut microbiome under healthy and stressed conditions. Sci Rep (2017) 0.75
Osteoarthritis: Chondroitin sulfate - CONCEPT clear, uncertainties unchanged. Nat Rev Rheumatol (2017) 0.75
A power primer. Psychol Bull (1992) 63.66
Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol (1988) 35.68
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain (2001) 16.05
Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum (2000) 11.84
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med (2006) 10.95
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) (2012) 9.25
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain (2007) 8.89
Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA (2000) 6.54
Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis (1989) 6.52
Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med (2007) 6.17
Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ (2010) 5.68
Assessment of pain. Br J Anaesth (2008) 5.35
Epidemiology of hip and knee osteoarthritis. Epidemiol Rev (1988) 4.45
EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2000) 4.37
OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage (2004) 4.01
The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum (1990) 3.97
Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis (2004) 3.95
The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emerg Med J (2001) 3.76
Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev (2006) 3.65
Does the clinically significant difference in visual analog scale pain scores vary with gender, age, or cause of pain? Acad Emerg Med (1998) 3.19
Exercise for osteoarthritis of the knee. Cochrane Database Syst Rev (2008) 3.09
Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med (2003) 3.07
Validity of four pain intensity rating scales. Pain (2011) 3.04
Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev (2005) 3.00
Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med (2002) 2.98
Effect of glucosamine sulfate on hip osteoarthritis: a randomized trial. Ann Intern Med (2008) 2.45
The epidemiology of knee osteoarthritis: results from the Framingham Osteoarthritis Study. Semin Arthritis Rheum (1990) 2.43
Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative. Osteoarthritis Cartilage (2000) 2.42
The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum (2008) 2.37
Responsiveness and clinically important differences for the WOMAC and SF-36 after total knee replacement. Osteoarthritis Cartilage (2006) 2.29
Acetaminophen for osteoarthritis. Cochrane Database Syst Rev (2006) 2.21
A randomized, double blind, placebo controlled trial of a topical cream containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee. J Rheumatol (2003) 2.20
Clinical versus statistical significance in the assessment of pain relief. Ann Emerg Med (1996) 1.90
The algofunctional indices for hip and knee osteoarthritis. J Rheumatol (1997) 1.72
The effect of glucosamine-chondroitin supplementation on glycosylated hemoglobin levels in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial. Arch Intern Med (2003) 1.69
Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum (2007) 1.69
Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthritis Rheum (2005) 1.63
Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2009) 1.54
Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT. Ann Rheum Dis (2010) 1.51
Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center. Arthritis Rheum (2011) 1.48
Supplements and injections for joint disease. Br J Hosp Med (Lond) (2006) 1.39
Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial. Am J Med (2004) 1.37
Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Cartilage (1994) 1.33
Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis Cartilage (1998) 1.26
Arthroscopic debridement for knee osteoarthritis. Cochrane Database Syst Rev (2008) 1.21
A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol (2000) 1.17
Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study. Ann Rheum Dis (2007) 1.16
Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis. Rheumatol Int (2009) 1.11
What is clinically meaningful: outcome measures in pain clinical trials. Clin J Pain (2000) 1.07
Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study. Mil Med (1999) 1.07
Tramadol for osteoarthritis. Cochrane Database Syst Rev (2006) 1.03
Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis. J Rheumatol (1996) 1.03
Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. Osteoarthritis Cartilage (1998) 1.02
Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am (1999) 1.01
Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthritis Cartilage (2000) 1.01
Use of complementary and alternative medicine among patients with radiographic-confirmed knee osteoarthritis. Osteoarthritis Cartilage (2011) 0.99
Costs of osteoarthritis: estimates from a geographically defined population. J Rheumatol Suppl (1995) 0.97
Disease-modifying therapies for osteoarthritis : current status. Drugs Aging (2005) 0.97
Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. Osteoarthritis Cartilage (2004) 0.97
Serum keratan sulfate is a promising marker of early articular cartilage breakdown. Rheumatology (Oxford) (2007) 0.96
Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration. Osteoarthritis Cartilage (2010) 0.94
Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs. Clin Rheumatol (2002) 0.94
Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study. J Rheumatol (2001) 0.93
Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo. Osteoarthritis Cartilage (1998) 0.92
Chondroitin sulfate and other sulfate containing chondroprotective agents may exhibit their effects by overcoming a deficiency of sulfur amino acids. Osteoarthritis Cartilage (2003) 0.91
Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA. Osteoarthritis Cartilage (1998) 0.89
'Natural remedies' in the treatment of osteoarthritis. Drugs Aging (2003) 0.89
Relevant change in radiological progression in patients with hip osteoarthritis. II. Determination using an expert opinion approach. Rheumatology (Oxford) (2002) 0.88
Effect of a dietary supplement containing glucosamine hydrochloride, chondroitin sulfate and quercetin glycosides on symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled study. J Sci Food Agric (2011) 0.88
OMERACT 6 Economics Working Group report: a proposal for a reference case for economic evaluation in rheumatoid arthritis. J Rheumatol (2003) 0.86
Effects of an orally administered mixture of chondroitin sulfate, glucosamine hydrochloride and manganese ascorbate on synovial fluid chondroitin sulfate 3B3 and 7D4 epitope in a canine cruciate ligament transection model of osteoarthritis. Osteoarthritis Cartilage (2001) 0.86
Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study. Osteoarthritis Cartilage (2010) 0.84
Effects of an oral administration of glucosamine-chondroitin-quercetin glucoside on the synovial fluid properties in patients with osteoarthritis and rheumatoid arthritis. Biosci Biotechnol Biochem (2009) 0.84
[Chondroitin sulfate in the treatment of gonarthrosis and coxarthrosis. 5-months result of a multicenter double-blind controlled prospective study using placebo]. Rev Rhum Mal Osteoartic (1993) 0.84
Glucosamine/chondroitin combined with exercise for the treatment of knee osteoarthritis: a preliminary study. Osteoarthritis Cartilage (2007) 0.83
Published meta-analyses of pharmacological therapies for osteoarthritis. Osteoarthritis Cartilage (2002) 0.83
[Anti-arthrosis treatments: efficacy and tolerance of chondroitin sulfates (CS 4&6)]. Presse Med (1998) 0.83
Effect of 12 months treatment with chondroitin sulfate on cartilage volume in knee osteoarthritis patients: a randomized, double-blind, placebo-controlled pilot study using MRI. Clin Rheumatol (2012) 0.81
Effect of a glucosamine-based combination supplement containing chondroitin sulfate and antioxidant micronutrients in subjects with symptomatic knee osteoarthritis: A pilot study. Exp Ther Med (2011) 0.80
Chondroitin sulfate in erosive osteoarthritis of the hands. Int J Tissue React (2002) 0.80
Galactosaminoglycuronoglycan sulfate (matrix) in therapy of tibiofibular osteoarthritis of the knee. Drugs Exp Clin Res (1991) 0.80
The effect of active absorbable algal calcium (AAA Ca) with collagen and other matrix components on back and joint pain and skin impedance. J Bone Miner Metab (2002) 0.79
Efficacy and safety of piascledine 300 versus chondroitin sulfate in a 6 months treatment plus 2 months observation in patients with osteoarthritis of the knee. Clin Rheumatol (2010) 0.79
Effects of diet type and supplementation of glucosamine, chondroitin, and MSM on body composition, functional status, and markers of health in women with knee osteoarthritis initiating a resistance-based exercise and weight loss program. J Int Soc Sports Nutr (2011) 0.79
Potential effects of chondroitin sulfate on joint swelling: a GAIT report. Osteoarthritis Cartilage (2008) 0.79
[Structum (chondroitin sulfate)--a new agent for the treatment of osteoarthrosis]. Ter Arkh (1999) 0.78
A two-year study of chondroitin sulfate in erosive osteoarthritis of the hands: behavior of erosions, osteophytes, pain and hand dysfunction. Drugs Exp Clin Res (2004) 0.78
[Results of the multicenter clinical trial of structum preparation in Russia]. Ter Arkh (2001) 0.78
A randomized double-blind clinical trial of the effect of chondroitin sulfate and glucosamine hydrochloride on temporomandibular joint disorders: a pilot study. Cranio (2001) 0.78
[Assessment of the placebo effect of symptomatic slow-acting anti-arthritics]. Presse Med (1998) 0.78
Total Knee Replacement as a Knee Osteoarthritis Outcome: Predictors Derived from a 4-Year Long-Term Observation following a Randomized Clinical Trial Using Chondroitin Sulfate. Cartilage (2013) 0.78
Therapeutic trials in digital osteoarthritis. A critical review. Rev Rhum Engl Ed (1995) 0.77
Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results of a randomized double blind placebo controlled study. Osteoarthritis Cartilage (2012) 0.77
New approaches to the treatment of osteoarthritis: oral glucosamine and chondroitin sulfate. Instr Course Lect (2000) 0.77
Clinical inquiries. Do glucosamine or chondroitin cause regeneration of cartilage in osteoarthritis? J Fam Pract (2003) 0.76
Combination of glycosaminoglycans and acetylsalicylic acid in knee osteoarthrosis. Scand J Rheumatol (1987) 0.76
[Beneficial effects of Chondrosulf 400 on pain and articular function in arthrosis: a meta-analysis]. Presse Med (2000) 0.76
[Medicaments as ointments in combined treatment of osteoarthrosis]. Ter Arkh (2000) 0.76
Do glucosamine and chondroitin treat the symptoms of osteoarthritis? Can Fam Physician (2001) 0.76
Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med (2008) 6.02
Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med (2011) 5.86
Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes. Ann Intern Med (2011) 3.53
Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline. Ann Intern Med (2007) 3.06
Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann Intern Med (2013) 2.66
Screening pelvic examinations in asymptomatic, average-risk adult women: an evidence report for a clinical practice guideline from the American College of Physicians. Ann Intern Med (2014) 2.13
Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med (2004) 2.12
Intermediate- and Long-Term Cognitive Outcomes After Cardiovascular Procedures in Older Adults: A Systematic Review. Ann Intern Med (2015) 2.12
Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review. Ann Intern Med (2015) 2.02
Comparative effectiveness of Clostridium difficile treatments: a systematic review. Ann Intern Med (2011) 1.98
Systematic review: repair of unruptured abdominal aortic aneurysm. Ann Intern Med (2007) 1.80
Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference. Ann Intern Med (2009) 1.72
Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol (2004) 1.71
Systematic review: effective management strategies for lactose intolerance. Ann Intern Med (2010) 1.69
Advanced wound care therapies for nonhealing diabetic, venous, and arterial ulcers: a systematic review. Ann Intern Med (2013) 1.62
Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis. Ann Intern Med (2009) 1.53
Teledermatology for diagnosis and management of skin conditions: a systematic review. J Am Acad Dermatol (2010) 1.43
Antibiotic prophylaxis for transurethral prostatic resection in men with preoperative urine containing less than 100,000 bacteria per ml: a systematic review. J Urol (2005) 1.39
Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann Intern Med (2012) 1.36
Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev (2009) 1.33
Update of strategies to translate evidence from cochrane musculoskeletal group systematic reviews for use by various audiences. J Rheumatol (2013) 1.18
Golimumab for rheumatoid arthritis. Cochrane Database Syst Rev (2010) 1.16
Association between hospital and surgeon radical prostatectomy volume and patient outcomes: a systematic review. J Urol (2008) 1.12
Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. Nicotine Tob Res (2007) 1.03
Lactose intolerance and health. Evid Rep Technol Assess (Full Rep) (2010) 1.01
Management of hyperglycemia, dyslipidemia, and albuminuria in patients with diabetes and CKD: a systematic review for a KDOQI clinical practice guideline. Am J Kidney Dis (2012) 1.01
Laser prostatectomy versus transurethral resection for treating benign prostatic obstruction: a systematic review. J Urol (2003) 0.96
Pharmacist-led Chronic Disease Management: A Systematic Review of Effectiveness and Harms Compared With Usual Care. Ann Intern Med (2016) 0.94
Carbohydrate and lipid disorders and relevant considerations in persons with spinal cord injury. Evid Rep Technol Assess (Full Rep) (2008) 0.94
Transurethral microwave thermotherapy vs transurethral resection for treating benign prostatic hyperplasia: a systematic review. BJU Int (2004) 0.92
Pharmacologic therapy for primary restless legs syndrome: a systematic review and meta-analysis. JAMA Intern Med (2013) 0.91
Endoscopic and medical therapy for chronic radiation proctopathy: a systematic review. Dis Colon Rectum (2012) 0.90
Tamsulosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects. J Urol (2002) 0.90
Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians. Ann Intern Med (2016) 0.89
Cost-effectiveness of abdominal aortic aneurysm repair: a systematic review. Int J Technol Assess Health Care (2007) 0.88
Oral sildenafil citrate (viagra) for erectile dysfunction: a systematic review and meta-analysis of harms. Urology (2009) 0.88
Clinical efficacy of OM-85 BV in COPD and chronic bronchitis: a systematic review. COPD (2005) 0.86
Management of chronic hepatitis B. Evid Rep Technol Assess (Full Rep) (2008) 0.86
Effectiveness of family and caregiver interventions on patient outcomes in adults with cancer: a systematic review. J Gen Intern Med (2014) 0.86
Golimumab for rheumatoid arthritis: a systematic review. J Rheumatol (2010) 0.83
Frequency of alcohol-impaired driving in New York State. Traffic Inj Prev (2011) 0.83
Antimicrobial stewardship programs in inpatient hospital settings: a systematic review. Infect Control Hosp Epidemiol (2014) 0.83
Psychological and Behavioral Interventions for Managing Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians. Ann Intern Med (2016) 0.83
Systematic review of the literature on comparative effectiveness of antiviral treatments for chronic hepatitis B infection. J Gen Intern Med (2011) 0.82
Updated method guidelines for cochrane musculoskeletal group systematic reviews and metaanalyses. J Rheumatol (2013) 0.82
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis. Cochrane Database Syst Rev (2016) 0.78
Diacerein for osteoarthritis. Cochrane Database Syst Rev (2014) 0.78
Doxazosin in the treatment of benign prostatic hypertrophy: an update. Clin Interv Aging (2006) 0.77
Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA). Cochrane Database Syst Rev (2016) 0.76
Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. Cochrane Database Syst Rev (2017) 0.75
Anticoagulant prophylaxis for hospitalized medical patients. Ann Intern Med (2007) 0.75
Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis. Cochrane Database Syst Rev (2017) 0.75
Calcium channel blockers for primary and secondary Raynaud's phenomenon. Cochrane Database Syst Rev (2017) 0.75